Eindhoven, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) has completed its first field study for its Minicare handheld cardiac Troponin-I (cTn-I) blood test, demonstrating the platform’s potential to produce lab-equivalent results with finger prick samples within minutes.
